ATVIO Biotech is recognized by Insights Care magazine in "The 10 Most Innovative Companies in Gene Therapy"

To read the full article please enter the link

ATVIO's ownership transfers from MaSTherCell Global back to Orgenesis Inc.

After 2 years of being MaSTherCell Global subsidiary, ATVIO is moving back to its original parent company, Orgenesis Inc.

To read more press here

Webinar: GMP for Cell Therapies - what you need to know?
Nufar Gross (GM) and Inbar Barzili (QA Director) are presenting the differences in GMP for cell therapy products compared with traditional biotech. The webinar also explores the expertise that is needed to manufacture high quality cell therapy products and how to transition from a typical lab environment to GMP clean rooms.
To listen the webinar press here.

We Need Robots to Make the Cancer Meds of the Future

An article written by Amos Zeeberg that highlights the need for automation in cell therapy industry.

For more information please press here

ATVIO celebrates its new facility grand opening

ATVIO will be the technology innovation center of the MasTHerCell global network

Read the press release

Seeking New Technologies To Advance Personalized Medicine- Bioprocess online


Read the article


The BIRD foundation awarded Atvio Biotech and Secant Group a grant to develop an innovative 3D culture platform


Read the press release

Cell therapy firms and vendors look to automation technologies

An article published by Bioprocess International on one of the biggest challenges in cell therapy industry.

Please read Dr. Ohad Karnieli quotations on this matter

An interview with Atvio CEO, Ohad Karnieli about the CMOs roll in the cell therapy industry


For the interview please press here

ATVIO- Turning Great Ideas to Revolutionary Solutions


Listen to Dr. Karnieli interview on the next revolution in cell therapy


Orgenesis and Atvio Biotech Launch Joint Venture for Gene and Cell Therapy Development Services


For more information please press here